top of page
June 10, 2025
Sensydia Awarded Second Phase of $3M NIH Grant to Advance CPS™ Clinical Utility
The NIH has activated Phase II funding of Sensydia’s Fast-Track STTR grant to support real-world clinical utility studies of the Cardiac Performance System (CPS™). This non-dilutive funding marks a key milestone as the company continues to validate CPS for patients with heart failure and pulmonary hypertension.
bottom of page